Antiarrhytmics Treatable Antiarrhytmics: Atrial Fibrillation, Atrial Flutter, Vtach and PSVT Drugs MOA Indication S/E Notes
Antiarrhytmics Treatable Antiarrhytmics: Atrial Fibrillation, Atrial Flutter, Vtach and PSVT Drugs MOA Indication S/E Notes
Antiarrhytmics Treatable Antiarrhytmics: Atrial Fibrillation, Atrial Flutter, Vtach and PSVT Drugs MOA Indication S/E Notes
Class Ib Fast sodium channel Helps stabilize Local anesthetic toxicity Lidocaine,
blockers that affect VTach in situations (CNS symptoms: Mexiletine,
phase 0 (depolarization) where heart is confusion, seizure) Tocainide
diseased or
Shorten action potential ischemic
duration but “Lettuce, Mayo,
preferentially binds to Tomato”
ischemic or abnormal
cells
Class Ic Fast sodium channel Supraventricular Contraindicated in Encainide,
blockers that affect tachycardia patients with heart Moracizine,
phase 0 (depolarization) disease dues to Flecainide,
proarrhytmic effect in Propafenone
Do not change action these patients
potential duration but “Eat More Fries
bids to Na channels most Please”
avidly, especially AV node
Class II Beta blockers; beta PSVT Heart block
adrenergic antagonists Afib Impotence
Aflutter Bradycardia
Stop sympathetic activity Bronchospasm
on the heart sedation
Decrease HR and AV
nodal conduction velocity
(increased PR interval on
ECG)
Class III Potassium channel Torsades de pointes Amiodarone (Class I
blockers that affect to IV activity),
phase 3 (repolarization) Amiodarone: Bretylium,
Photosensitivity Dofetilide, Ibutilide,
Prolongs action potential Pulmonary fibrosis Sotalol (beta
Prolongs refractory (check PFTs) blocker but is Class
period Thyroid function (iodine III)
in drug causes thyroid
abnormalities) and “A Big Dog Is Scary”
hepatotoxicity (check
LFTs)
Decrease rapidity of SA
node depolarization